Stay updated on AVANZAR Clinical Trial: Dato-DXd Combo in NSCLC

Sign up to get notified when there's something new on the AVANZAR Clinical Trial: Dato-DXd Combo in NSCLC page.
Latest website image capture
Clouds background image

Latest updates to the AVANZAR Clinical Trial: Dato-DXd Combo in NSCLC page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.3%
    Check dated 2024-06-13T22:26:32.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in medical or healthcare-related publications or documentation.
    Difference
    0.3%
    Check dated 2024-06-06T14:41:04.000Z thumbnail image
  7. Check
    17 days ago
    Change Detected
    Summary
    The value 04 09 has been updated to 05 29 on the webpage, indicating a recent change in the study details related to a Phase III clinical trial for advanced NSCLC involving Dato-DXd in combination with Durvalumab and Carboplatin without actionable genomic alterations.
    Difference
    0.7%
    Check dated 2024-05-30T09:41:09.000Z thumbnail image
  8. Check
    24 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of certain medical or healthcare-related publications or documentation. This change may reflect new information or additional entries in the relevant category.
    Difference
    0.3%
    Check dated 2024-05-22T21:31:34.000Z thumbnail image
  9. Check
    46 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:39:07.000Z thumbnail image

Stay in the know with updates to AVANZAR Clinical Trial: Dato-DXd Combo in NSCLC

Enter your email address, and we'll notify you when there's something new on the AVANZAR Clinical Trial: Dato-DXd Combo in NSCLC page.